Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Current Opinion in Pharmacology
|
January 29, 2003
Recent developments from genetic mouse models of seizures
Neil Upton, Sharon Stratton
Biomarkers in Medicine
|
May 19, 2010
Symptomatic treatment of Alzheimer's disease: identification of biomarkers to aid translation from bench to bedside
Elaine A Irving, Neil Upton
Experimental Dermatology
|
August 1, 2014
Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour
Michael K Trower, Amy Fisher, Neil Upton, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 16, 2008
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
Neil Upton, Tsu Tshen Chuang, Ann J Hunter, et al.
Frontiers in Pharmacology
|
February 25, 2021
Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
Amy S Fisher, Michael T Lanigan, Neil Upton, et al.
Behavioural Brain Research
|
January 19, 2007
Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease
Perdita L Pugh, Jill C Richardson, Simon T Bate, et al.
Behavioural Brain Research
|
September 15, 2004
A behavioural characterisation of the FVB/N mouse strain
Perdita L Pugh, Sharlin F Ahmed, Martin I Smith, et al.
Brain Topography
|
March 19, 2013
Age-related task sensitivity of frontal EEG entropy during encoding predicts retrieval
Denis O'Hora, Stefan Schinkel, Michael J Hogan, et al.
Experimental Brain Research
|
May 18, 2011
Electroencephalographic coherence, aging, and memory: distinct responses to background context and stimulus repetition in younger, older, and older declined groups
Michael Hogan, Peter Collins, Michael Keane, et al.
Neuropharmacology
|
July 7, 2012
Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457
Charlotte K Callaghan, Vincent Hok, Andrea Della-Chiesa, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Current Opinion in Pharmacology
|
January 29, 2003
Recent developments from genetic mouse models of seizures
Neil Upton, Sharon Stratton
Biomarkers in Medicine
|
May 19, 2010
Symptomatic treatment of Alzheimer's disease: identification of biomarkers to aid translation from bench to bedside
Elaine A Irving, Neil Upton
Experimental Dermatology
|
August 1, 2014
Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour
Michael K Trower, Amy Fisher, Neil Upton, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 16, 2008
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
Neil Upton, Tsu Tshen Chuang, Ann J Hunter, et al.
Frontiers in Pharmacology
|
February 25, 2021
Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
Amy S Fisher, Michael T Lanigan, Neil Upton, et al.
Behavioural Brain Research
|
January 19, 2007
Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease
Perdita L Pugh, Jill C Richardson, Simon T Bate, et al.
Behavioural Brain Research
|
September 15, 2004
A behavioural characterisation of the FVB/N mouse strain
Perdita L Pugh, Sharlin F Ahmed, Martin I Smith, et al.
Brain Topography
|
March 19, 2013
Age-related task sensitivity of frontal EEG entropy during encoding predicts retrieval
Denis O'Hora, Stefan Schinkel, Michael J Hogan, et al.
Experimental Brain Research
|
May 18, 2011
Electroencephalographic coherence, aging, and memory: distinct responses to background context and stimulus repetition in younger, older, and older declined groups
Michael Hogan, Peter Collins, Michael Keane, et al.
Neuropharmacology
|
July 7, 2012
Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457
Charlotte K Callaghan, Vincent Hok, Andrea Della-Chiesa, et al.
Page
of 6